Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of SEDRONATE 35 mg vs Actonel Once-a-Week 35 mg in healthy adults under fasting conditions
TCTR20190329002Not yet recruiting
- Sponsor
- Government Pharmaceutical Organization
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of risedronate in osteoporosis (2 arms), sponsored by Government Pharmaceutical Organization. Planned start May 2019; status: not yet recruiting.
02
Drugs
risedronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on TCTR20190329002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190329002.